Cargando…

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ

OBJECTIVES: Biological markers that predict the development of invasive breast cancer are needed to improve personalized therapy for patients diagnosed with ductal carcinoma in situ. We investigated the role of basal cytokeratin 5/6 in the risk of invasion in breast ductal carcinoma in situ. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguiar, Fernando N., Mendes, Henrique N., Cirqueira, Cinthya S., Bacchi, Carlos E., Carvalho, Filomena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654300/ https://www.ncbi.nlm.nih.gov/pubmed/23778411 http://dx.doi.org/10.6061/clinics/2013(05)010

Ejemplares similares

Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
por: Lyu, Su Ir, et al.
Publicado: (2023)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion
por: de Freitas, Daniela, et al.
Publicado: (2018)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer
por: Gusterson, Barry A, et al.
Publicado: (2005)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Immunohistochemical Studies of Cytokeratins and Differentiation Markers in Bovine Ocular Squamous Cell Carcinoma
por: Vala, Helena, et al.
Publicado: (2020)

Asynchronous LOH analysis of ductal carcinoma in situ from patients who subsequently developed invasive ductal carcinoma
por: Amari, M, et al.
Publicado: (2001)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
por: Doebar, S. C., et al.
Publicado: (2018)

Cytokeratin Profile of Basal Cell Carcinomas According to the Degree of Sun Exposure and to the Anatomical Localization
por: García-de-la-Fuente, Mª Reyes, et al.
Publicado: (2018)

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
por: Li, Zheqi, et al.
Publicado: (2022)

Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
por: Muilwijk, Tim, et al.
Publicado: (2021)

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast
por: Robanus-Maandag, E, et al.
Publicado: (2000)

Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ
por: Chade, Milca Cezar, et al.
Publicado: (2018)

Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
por: Kothari, Charu, et al.
Publicado: (2021)

Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
por: Zubeldia-Plazaola, Arantzazu, et al.
Publicado: (2018)

Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma
por: Song, Guiqin, et al.
Publicado: (2019)

Triexponential Diffusion Analysis of Diffusion-weighted Imaging for Breast Ductal Carcinoma in Situ and Invasive Ductal Carcinoma
por: Ohno, Masako, et al.
Publicado: (2021)

Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment
por: Chen, Weiling, et al.
Publicado: (2022)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study
por: Guan, Xin, et al.
Publicado: (2020)

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
por: Tamimi, Rulla M, et al.
Publicado: (2008)

SOX11 promotes invasive growth and ductal carcinoma in situ progression
por: Oliemuller, Erik, et al.
Publicado: (2017)

In Situ and Invasive Ductal Carcinoma Within a Borderline Phyllodes Tumor
por: Trabelsi, Amel, et al.
Publicado: (2010)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
por: Johnson, Kevin C., et al.
Publicado: (2015)

Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer
por: Wang, Chung-Chieh, et al.
Publicado: (2019)

Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ
Publicado: (1988)

Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery
por: Ramos, Marcus Fernando Kodama Pertille, et al.
Publicado: (2021)

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report
Publicado: (2022)

Cytokeratin 15 Marks Basal Epithelia in Developing Ureters and Is Upregulated in a Subset of Urothelial Cell Carcinomas
por: Tai, Guangping, et al.
Publicado: (2013)

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
por: Makino, T, et al.
Publicado: (2009)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Cytokeratin Autoantibodies: Useful Serologic Markers for Toluene Diisocyanate-Induced Asthma
por: Ye, Young-Min, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_j582bt7bsdgdj1cajp0ucgkaev